278 related articles for article (PubMed ID: 20850954)
1. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
2. Emodin inhibits the growth of hepatoma cells: finding the common anti-cancer pathway using Huh7, Hep3B, and HepG2 cells.
Hsu CM; Hsu YA; Tsai Y; Shieh FK; Huang SH; Wan L; Tsai FJ
Biochem Biophys Res Commun; 2010 Feb; 392(4):473-8. PubMed ID: 19895793
[TBL] [Abstract][Full Text] [Related]
3. Gene expressions associated with chemosensitivity in human hepatoma cells.
Hoshida Y; Moriyama M; Otsuka M; Kato N; Taniguchi H; Shiratori Y; Seki N; Omata M
Hepatogastroenterology; 2007 Mar; 54(74):489-92. PubMed ID: 17523305
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory and apoptosis inducing effect of Perilla frutescens extract on human hepatoma HepG2 cells.
Lin CS; Kuo CL; Wang JP; Cheng JS; Huang ZW; Chen CF
J Ethnopharmacol; 2007 Jul; 112(3):557-67. PubMed ID: 17574356
[TBL] [Abstract][Full Text] [Related]
6. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells.
Chiang LC; Ng LT; Lin IC; Kuo PL; Lin CC
Cancer Lett; 2006 Jun; 237(2):207-14. PubMed ID: 16023288
[TBL] [Abstract][Full Text] [Related]
8. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
9. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
10. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
[TBL] [Abstract][Full Text] [Related]
11. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
Choedon T; Dolma D; Kumar V
J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
[TBL] [Abstract][Full Text] [Related]
12. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
[TBL] [Abstract][Full Text] [Related]
13. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
[TBL] [Abstract][Full Text] [Related]
14. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
15. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.
Jie X; Lang C; Jian Q; Chaoqun L; Dehua Y; Yi S; Yanping J; Luokun X; Qiuping Z; Hui W; Feili G; Boquan J; Youxin J; Jinquan T
Oncogene; 2007 Aug; 26(39):5741-51. PubMed ID: 17369855
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.
Fang EF; Zhang CZ; Zhang L; Fong WP; Ng TB
Int J Biochem Cell Biol; 2012 Aug; 44(8):1351-60. PubMed ID: 22554586
[TBL] [Abstract][Full Text] [Related]
17. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]